Search

Your search keyword '"Tranexamic acid -- Intellectual property"' showing total 19 results

Search Constraints

Start Over You searched for: Descriptor "Tranexamic acid -- Intellectual property" Remove constraint Descriptor: "Tranexamic acid -- Intellectual property" Topic editors Remove constraint Topic: editors
19 results on '"Tranexamic acid -- Intellectual property"'

Search Results

1. Patent Issued for Medical Wound Covering Employing Electrical Stimulation To Control Blood Flow (USPTO 10,646,710)

2. Patent Application Titled 'Apparatus For Forming Delivery Path For Composition For Treatment And Auxiliary Assembly For Skin Treatment Including Same' Published Online (USPTO 20200139096)

3. Patent Issued for Oral Combination Drug Formulation Comprising A Non-Steroidal Anti-Inflammatory Drug And A Complementary Low Dose Of Tranexamic Acid For The Treatment Of Menstrual Pain Accompanied With Excessive Menstrual Blood Loss (USPTO 10,532,037)

4. Patent Issued for RNA Complexes That Inhibit Melanin Production (USPTO 10,512,600)

5. Patent Application Titled 'Preparation Of Microparticles Of An Active Ingredient' Published Online (USPTO 20190380967)

6. Researchers Submit Patent Application, 'Medical Wound Covering Employing Electrical Stimulation To Control Blood Flow', for Approval (USPTO 20190366083)

8. Researchers Submit Patent Application, 'Patch-Type Wound Dressing Comprising Methylene Blue Mixture For Treating Skin Wound', for Approval (USPTO 20190224134)

9. 'Tranexamic Acid Oral Solution' in Patent Application Approval Process (USPTO 20190224121)

10. Researchers Submit Patent Application, 'Treatment Of Uterine Fibroids By Intravaginal Administration Of A Low Dose Of Selective Progesterone Receptor Modulator (Sprm), Anti-Progestin, Or Anti-Progestational Agent', for Approval (USPTO 201902014

11. Researchers Submit Patent Application, 'Transdermal Pharmaceutical Compositions With Reduced Skin Irritation', for Approval (USPTO 20190192662)

12. Patent Application Titled 'Treatment Of Excessive Menstrual Blood Loss By Feminine Sanitary Products Medicated With Hemostatic Agent' Published Online (USPTO 20190151634)

13. Patent Issued for Gadolinium Complex Comprising DO3A-Tranexamic Acid Conjugate (USPTO 10,245,328)

14. Patent Issued for Oral Care Compositions (USPTO 10,583,074)

17. Patent Application Titled 'Peptide' Published Online (USPTO 20190092814)

19. Researchers Submit Patent Application, 'Rna Complexes That Inhibit Melanin Production', for Approval (USPTO 20190038538)

Catalog

Books, media, physical & digital resources